Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 2000 Jan 3;191(1):189–194. doi: 10.1084/jem.191.1.189

P-Selectin or Intercellular Adhesion Molecule (Icam)-1 Deficiency Substantially Protects against Atherosclerosis in Apolipoprotein E–Deficient Mice

Robert G Collins a, Rizwan Velji a, Natalia V Guevara b, M John Hicks c, Lawrence Chan b,d, Arthur L Beaudet a,b
PMCID: PMC2195808  PMID: 10620617

Abstract

The expression of leukocyte and endothelial cell adhesion molecules (CAMs) is essential for the emigration of leukocytes during an inflammatory response. The importance of the inflammatory response in the development of atherosclerosis is indicated by the increased expression of adhesion molecules, proinflammatory cytokines, and growth factors in lesions and lesion-prone areas and by protection in mice deficient in various aspects of the inflammatory response. We have quantitated the effect of deficiency for intercellular adhesion molecule (ICAM)-1, P-selectin, or E-selectin on atherosclerotic lesion formation at 20 wk of age in apolipoprotein (apo) E−/− (deficient) mice fed a normal chow diet. All mice were apo E−/− and CAM+/+ or CAM−/− littermates, and no differences were found in body weight or cholesterol levels among the various genotypes during the study. ICAM-1−/− mice had significantly less lesion area than their ICAM-1+/+ littermates: 4.08 ± 0.70 mm2 for −/− males vs. 5.87 ± 0.66 mm2 for +/+ males, and 3.95 ± 0.65 mm2 for −/− females vs. 5.59 ± 1.131 mm2 for +/+ females, combined P < 0.0001. An even greater reduction in lesion area was observed in P-selectin−/− mice: 3.06 ± 1.04 mm2 for −/− males vs. 5.09 ± 1.22 mm2 for +/+ males, and 2.85 ± 1.26 mm2 for −/− females compared with 5.60 ± 1.19 mm2 for +/+ females, combined P < 0.001. The reduction in lesion area for the E-selectin null mice, although less than that seen for ICAM-1 or P-selectin, was still significant (4.54 ± 2.14 mm2 for −/− males vs. 5.92 ± 0.63 mm2 for +/+ males, and 4.38 ± 0.85 mm2 for −/− females compared with 5.94 ± 1.44 mm2 for +/+ females, combined P < 0.01). These results, coupled with the closely controlled genetics of this study, indicate that reductions in the expression of P-selectin, ICAM-1, or E-selectin provide direct protection from atherosclerotic lesion formation in this model.

Keywords: E-selectin, cell adhesion molecules, aorta, cholesterol, intercellular adhesion molecule-1

Introduction

The development of atherosclerosis is influenced by many genetic and environmental factors. These include diet, smoking, and variations in lipid metabolism genes 1. Evidence also suggests a role for the inflammatory response in the pathogenesis of atherosclerosis with the adhesion of circulating leukocytes, especially monocytes, to the endothelium at sites of injury 2 3. Leukocyte adhesion and emigration into the subendothelial space, in response to chemoattractants and other activating molecules, is mediated by leukocyte and endothelial cell adhesion molecules (CAMs). After migration into particular lesion-prone areas of the arterial vasculature, some monocytes ingest lipids and become foam cells, initiating a complex chain of events ending in lesion development 2 3.

Leukocyte emigration from the vasculature occurs in several steps regulated by distinct adhesion molecules. Leukocytes first undergo E-, L-, and P-selectin–mediated rolling along the endothelial surface, followed by firm attachment involving the β1- and β2-integrins and Ig adhesion superfamily members such as intercellular adhesion molecule (ICAM)-1 and vascular (V)CAM-1 4. Several of these molecules, including ICAM-1, VCAM-1, E-selectin, and P-selectin, show increased expression in atherosclerotic lesions 5 6 7 8 9. This includes studies in mice, rabbits, and humans and also includes evidence that a high-fat diet increases expression of various CAMs.

Because of the major potential for genetic manipulation in the mouse 10, a variety of strategies including transgenic overexpression, inactivating mutations induced by homologous recombination, and blocking mAbs have been used to study the relationships between leukocyte and endothelial CAMs and other aspects of the inflammatory process associated with atherosclerosis as reviewed elsewhere 11. Antibodies to α4-integrin and ICAM-1 have been used in apolipoprotein (apo) E−/− (deficient) mice to demonstrate reduction in recruitment of monocytes to atherosclerotic plaques 12. A blocking antibody to CD40 ligand decreased atherosclerosis in low density lipoprotein receptor (LDLR)−/− mice fed a high-cholesterol diet, with a demonstrated effect on both macrophages and lymphocytes 13. Osteopetrotic mice lacking macrophage colony-simulating factor were protected against atherosclerosis under a variety of conditions 14 15. In apo E−/− mice fed a high-fat diet, deficiency for the monocyte chemoattractant protein 1 receptor, CCR2, reduced lesions 16.

Various studies have directly assessed mice lacking expression of one or more CAMs for the effect on atherosclerosis. In a study using C57BL/6 mice fed a high-fat diet, a 50–75% reduction in atherosclerotic fatty streaks was found in mice deficient for ICAM-1, P-selectin, or CD18 17. In studies of mice deficient for P-selectin or both P- and E-selectin conducted with LDLR−/− mice, a modest effect was seen in male but not female mice lacking P-selectin, whereas a more substantial reduction in lesions was seen in the P- and E-selectin double-deficient mice 18 19. The P- and E-selectin double-mutant mice develop inflammatory skin disease, which might influence lesion development 20 21, and the studies of C57BL/6 and LDLR−/− mice involved use of a diet high in cholesterol and cholic acid, the latter being an abnormal supplement to the diet that can itself induce a chronic inflammatory state 10. In a study of leukocyte rolling in the carotid arteries of apo E−/− mice fed a high-fat diet, blocking mAbs to P-selectin or P-selectin ligand 1 decreased mononuclear cell attachment and rolling, whereas blocking antibodies to α4-integrin or VCAM-1 increased rolling velocities 22.

We wished to study the effect of genetic deficiency for three individual CAMs (P-selectin, ICAM-1, and E-selectin) in the apo E−/− mouse model, in which mice develop spontaneous lesions in the arterial vasculature with advanced lesions morphologically similar to those seen in humans when fed a regular chow, high-fat, or high-cholesterol diet 23 24 25. Even with a mouse chow diet low in fat and cholesterol, apo E−/− mice develop spontaneous atherosclerosis including fibroproliferative lesions 24 25 26 27 similar to those seen in humans. In the apo E−/− mice on normal chow, we observed substantial reduction in lesions with P-selectin or ICAM-1 deficiency and marginal effects with E-selectin deficiency.

Materials and Methods

Animals and Diet.

The ICAM-1 28, P-selectin 29, and E-selectin 20 mice were generated in our laboratory and were backcrossed onto a C57BL/6 background a minimum of six generations (N6). Apo E−/− mice 23 were obtained from The Jackson Laboratory and were also backcrossed to C57BL/6 (N6). Mice of the genotype apo E−/−CAM−/− were generated by matings between the two mutant mouse strains and their progeny to produce three strains of mice double mutant for apo E and ICAM-1, P-selectin, or E-selectin. See Fig. 1 for the breeding scheme used to generate the study mice. One double mutant from each group (apo E−/−CAM−/−) was crossed back to apo E−/− mice (apo E−/− CAM+/+) to generate apo E−/−CAM+/− mice. The progeny of these mice were used in the study. All mice in each adhesion molecule arm of the study were descendants of the same apo E−/− CAM−/− and apo E−/− grandparental mice. The mice were fed standard mouse chow (Ralston Purina 5001) containing 6% fat and 0.0275% cholesterol from weaning until 20 wk of age. Mice were then killed for lesion analysis. Animals were housed in clean facilities with sentinel animals that consistently tested negative for common viral pathogens. Food and water were provided ad libitum, and an alternating 12-h light–dark cycle was maintained.

Figure 1.

Figure 1

Open in a new tab

Breeding scheme for generating study animals. All animals in the study were apo E−/−. The animals for each CAM mutation are all descendants of a single founder pair of mice.

Cholesterol Determination.

Blood was collected from the retroorbital venus plexus of anesthetized mice after fasting overnight (16–18 h). Total plasma cholesterol was determined using an enzymatic assay (cholesterol kit 352-20; Sigma Diagnostics) according to the manufacturer's instructions. Cholesterol was separated into very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL)/LDL, and high density lipoprotein (HDL) fractions, subjecting 0.1 ml of plasma to fast performance liquid chromatography gel filtration on two Superose 6 columns (Pharmacia Biotech Inc.) connected in series as described 30. 40 0.5-ml fractions were collected, and cholesterol in each was determined as above, with fractions 6–25 containing VLDL+IDL+LDL and fractions 27–35 containing HDL.

Quantitation of Lesion Area.

At 20 wk of age, the mice were killed and their aortas isolated. Aortas were mounted and lesion areas quantitated as described by a person blinded to the genotypes 31. In brief, the cleaned aortas were cut open longitudinally, pinned onto cardboard, and fixed in formalin. After staining with Oil Red O (Sigma Chemical Co.) and mounting on glass slides, the aortas were scanned at high resolution with a SprintScan 35 slide scanner (Polaroid). Lesion areas were then calculated from the scanned images.

Histopathology.

The aortas from three C57BL/6 wild-type, three apo E−/− with no CAM deficiency, three apo E−/−ICAM-1−/−, and three apo E−/−P-selectin−/− animals were fixed in formalin, dehydrated through graded alcohol and xylene, and then embedded in paraffin. Serial 5-μm-thick tissue sections were performed, stained with hematoxylin and eosin, and evaluated microscopically in a blinded fashion for lesions. Representative photomicrographs were taken from each specimen for comparison among the groups.

Statistical Analysis.

Statistical analysis of the data generated was conducted with Statview (version 4.5; Abacus Concepts, Inc.) statistical analysis software. Two-way analysis of variance (ANOVA) was used to determine the effects of genotype, gender, and the interaction between genotype and gender. This analysis was completed for each of the independent CAM genes tested.

Results

Production of Study Mice.

With the starting mice all being backcrossed (≥N6) and all study mice for each CAM descended from the same grandparental breeding pair ( Fig. 1), the mice used had minimal genetic variation apart from the CAM genotype. Offspring of the breeding pairs, all apo E−/− and +/+, +/−, or −/− for the CAM, were considered as grouped littermates and were kept on the chow diet from weaning until 20 wk of age before the aortas were harvested. There was no difference in appearance or weight (data not shown) of the males or females in any group.

Cholesterol Analysis.

Total cholesterol levels were measured in all of the mice for the duration of the study to monitor for possible differences in cholesterol levels (Table ). A Kruskal-Wallis nonparametric ANOVA test indicated no differences in total cholesterol or HDL cholesterol among animals within each experimental group or at any time point during the study. This was true in all groups for 4-wk time points, CAM genotypes, and sexes of mice.

Table 1.

Plasma Cholesterol Levels in Study Mice

Genotype Total cholesterol HDL cholesterol
mg/dl ± SD mg/dl ± SD
apo E−/−CAM+/+ (n = 50) 487 ± 152 35 ± 14
apo E−/−ICAM-1−/− (n = 13) 471 ± 123 41 ± 17
apo E−/−P-selectin−/− (n = 19) 495 ± 134 45 ± 18
apo E−/−E-selectin−/− (n = 18) 503 ± 139 39 ± 15
Open in a new tab

Mice were fed a mouse chow diet from weaning until 20 wk of age, and plasma cholesterol was determined as described in Materials and Methods at 8, 12, 16, and 20 wk for all mice in the study (n = 100). There was no difference in cholesterol levels (Kruskal-Wallis nonparametric ANOVA) for the time points or sexes within each experimental group (CAM mutation), so they were combined. The amount of HDL cholesterol was determined using fast performance liquid chromatography for five mice in each group with no difference among groups. There was also no significant difference in the cholesterol levels for any experimental group of mice (Kruskal-Wallis).

Lesion Analysis.

Atherosclerotic lesions are more likely to be observed in specific areas of the aorta. These include the valve cusps, aortic arch, and the abdominal aorta in the region of the renal arteries ( Fig. 2). Smaller lesions including fatty streaks were seen throughout the aorta but were more common at arterial branch points. Cross-sections of the most advanced lesions found in C57BL/6 wild-type, apo E−/− with no CAM deficiency, apo E−/−ICAM-1−/−, and apo E−/−P-selectin−/− mice are shown in Fig. 3. The calcification seen in the advanced lesions of apo E−/− mice was not observed in any of the aortas analyzed from ICAM-1 or P-selectin null mice. The most advanced lesions seen in the P-selectin−/− mice contained foam cells within expanded intima.

Figure 2.

Figure 2

Open in a new tab

Oil Red O–stained lesions on aortas from apo E−/− mice. (A and B) Representative aortas from P-selectin+/+ and ICAM-1+/+ males, respectively. Total lesion area on these aortas was 5.81 mm2 for A and 6.26 mm2 for B. Arrows point to more advanced lesions in the aortic arch. (C and D) Aortas from two P-selectin−/− males with total lesion areas of 3.08 and 2.91 mm2, respectively. Note the relative absence of lesions throughout the aorta compared with CAM+/+ mice in A and B. (E and F) Aortas from ICAM-1−/− mice with lesion areas of 4.38 and 3.90 mm2, respectively. Early lesions are present in the aortic arch.

Figure 3.

Figure 3

Open in a new tab

Histopathologic comparison of aortas from study animals. Sections shown are typical of the most advanced lesions found in animals of each genotype. (A) C57BL/6 wild-type murine aorta with intact intimal (top), unremarkable media (middle), and adventitial (bottom) layers with no evidence of atheromatous lesion. (B) Aorta from apo E−/− mouse with no CAM deficiency showing well formed atheromatous plaque characterized by foam cells, cell debris, cholesterol clefts, and calcification (arrow) within the expanded intima. Lesions exhibiting the calcification seen only in very advanced lesions were only found in apo E−/− mice with no CAM deficiency. (C) Aorta from an apo E−/−ICAM-1−/− animal with lesion composed of foam cells, cholesterol clefts, and extracellular lipid in expanded intima (arrow). (D) Aorta from apo E−/− P-selectin−/− animal with less developed atherosclerotic lesions (arrows) composed of frequent foam cells within expanded intima. Note relatively normal aortic segment between atheromatous lesions. (All hematoxylin and eosin stain with original magnification of 200).

There was very little size variation among the aortas due to the consistent size of the mice. The area for atherosclerotic lesions was determined, comparing the effect deficiency for ICAM-1, P-selectin, and E-selectin in apo E−/− mice, with each gene defining an independent experimental group of animals. Two-way ANOVA showed no significant interaction effect between genotype and gender (ICAM-1, P = 0.81; P-selectin, P = 0.33; and E-selectin, P = 0.55); therefore, male and female lesion area data were combined for calculation of statistical significance. As shown in Fig. 4, mice homozygous null for the ICAM-1 mutation had significantly less lesion formation than their ICAM-1+/+ littermates (4.08 ± 0.70 mm2 for −/− males vs. 5.87 ± 0.66 mm2 for +/+ males, and 3.95 ± 0.65 mm2 for −/− females vs. 5.59 ± 1.13 mm2 for +/+ females, combined P < 0.001). Also shown in Fig. 4 is an even greater reduction of lesion area in P-selectin−/− mice (3.06 ± 1.04 mm2 for −/− males vs. 5.09 ± 1.22 mm2 for +/+ males, and 2.85 ± 1.26 mm2 for −/− females compared with 5.60 ± 1.19 mm2 for +/+ females, combined P < 0.001). Most of the aortas from P-selectin−/− mice were remarkably free of lesions except for the valve cusps. The reduction in lesion area for E-selectin null mice, although less than that seen for ICAM-1 or P-selectin, was still significant (4.54 ± 2.14 mm2 for −/− males vs. 5.92 ± 0.63 mm2 for +/+ males, and 4.38 ± 0.85 mm2 for −/− females vs. 5.92 ± 1.44 mm2 for +/+ females, combined P < 0.01). None of the mice heterozygous for CAM had differences in lesion areas compared with apo E−/− CAM+/+ mice (data not shown). The lesion area data collected follows a normal distribution, with significant protection from the development of atherosclerosis observed in animals with null mutations in each independent adhesion molecule.

Figure 4.

Figure 4

Open in a new tab

Effect of CAM deficiency on lesion area in apo E−/− mice. Each data point represents total lesion area (mm2) in an animal's aorta between the aortic valve and the iliac branch for the sex and genotype shown. Error bars represent mean ± SD. Significant reduction in lesion area was seen in the animals of each experimental group (CAM mutation) with the P values shown. Along with the rigid control of genetics and husbandry, two-way ANOVA indicated that the protection seen was due to genotype, with no significant contribution from gender.

Discussion

As reviewed in the Introduction, extensive studies have demonstrated increased expression of leukocyte and endothelial CAMs in atherosclerotic lesions, and genetic manipulation has been used extensively in the mouse to study the pathogenesis of atherosclerosis. In previous studies using a high-fat diet containing cholic acid, individual CAM deficiencies in C57BL/6 mice 17 and P-selectin or P- and E-selectin deficiency in LDLR−/− mice 18 19, reduction in lesion formation was observed. The studies presented here demonstrate a reduction in atherosclerotic lesions using a more normal low-fat, low-cholesterol mouse chow diet in the apo E−/− mouse model. Importantly, the mice were healthy, closely matched for genetic background and husbandry, and showed no differences in plasma cholesterol. The ICAM-1−/− mice demonstrated a 30% reduction in lesions, and the P-selectin−/− mice demonstrated a 45% reduction in lesions at 20 wk of age; the differences were highly statistically significant for CAM−/− compared with CAM+/+ mice. Lesion reduction in E-selectin−/− mice was not as great, with 24% reduction in lesion area. Histopathological sections show that although foam cells are present in P-selectin null mice and extracellular lipids and cholesterol clefts occur in ICAM-1 null mice, the calcification seen in the very advanced lesions of CAM+/+ mice were not found in any of the mice lacking ICAM-1 or P-selectin. Studies of this type can be carried out under many different circumstances, including transgenic expression of lipoprotein(a) or cholesteryl ester transfer protein, various dietary conditions, increased homocysteine levels, and genetic deficiency for various CAMs and other inflammatory molecules. The studies reported here demonstrate that deficiency of P-selectin, ICAM-1, or E-selectin provides substantial reduction in lesions in apo E−/− mice fed a normal chow (low-fat) diet.

There is extensive evidence that monocytes play a pivotal role in the pathogenesis of atherosclerosis 2 3 14 15. Ligands for the three adhesion molecules examined in this study are expressed on the surfaces of monocytes, and their expression is upregulated upon monocyte activation 32. It can be argued that leukocyte and endothelial CAMs play a pivotal role in the pathogenesis of atherosclerosis, and that the effects of many risk factors might be mediated through effects on CAMs. Multiple reports demonstrate that cigarette smoking promotes leukocyte and endothelial adhesion reactions 33 34 35. There is also evidence to suggest that hyperglycemia and diabetes mellitus might increase the expression of leukocyte and/or endothelial CAMs 36 37 38, and shear stress selectively upregulates expression of ICAM-1 39. Modified LDL can increase the expression of CAM 40 41, and the antiatherogenic effect of probucol may be mediated by reducing the expression of VCAM-1, P-selectin, and other inflammatory mediators 42. There is a positive association of soluble CAMs with carotid atherosclerosis 43. Genetic polymorphisms in selectins may influence the risk of atherosclerosis in humans 44 45, and two reports support the association of a serine→arginine mutation at codon 128 of E-selectin with coronary artery disease 46 47. There is also a suggestion that lipoprotein Lp(a) may mediate its proatherogenic effect through upregulation of VCAM-1 and E-selectin 48. It remains to be determined if strategies to reduce the expression or adhesion of leukocyte and endothelial CAMs can be used to achieve protection against atherosclerosis in a clinical setting.

Acknowledgments

We wish to acknowledge Dr. Klaus Ley and E. O'Brien Smith, Ph.D., biostatistician of the Children's Nutritional Research Center, Baylor College of Medicine, for helpful discussions and critical review of the manuscript. Tanya Allen, Martin Idunoba, and Felton Nails provided technical assistance with histopathology.

A.L. Beaudet was an Investigator with the Howard Hughes Medical Institute during the time that most of this work was performed. This work was also supported by National Institutes of Health grants HL 51586 (to L. Chan) and AI 32117 (to A.L. Beaudet).

References

  1. McGill H.C., Jr. Overview. In: Fuster V., Ross R., Topol E.J., editors. Atherosclerosis and Coronary Artery Disease. Lippincott-Raven; Philadelphia : 1996. pp. 25–41. [Google Scholar]
  2. Ross R. The pathogenesis of atherosclerosisa perspective for the 1990s. Nature. 1993;362:801–809 . doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  3. Ross R. Atherosclerosis—an inflammatory disease. N. Engl. J. Med. 1999;340:115–126 . doi: 10.1056/NEJM199901143400207. [DOI] [PubMed] [Google Scholar]
  4. Springer T.A. Traffic signals for lymphocyte recirculation and leukocyte emigrationthe multistep paradigm. Cell. 1994;76:301–314 . doi: 10.1016/0092-8674(94)90337-9. [DOI] [PubMed] [Google Scholar]
  5. Richardson M., Hadcock S.J., DeReske M., Cybulsky M.I. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler. Thromb. 1994;14:760–769 . doi: 10.1161/01.atv.14.5.760. [DOI] [PubMed] [Google Scholar]
  6. Poston R.N., Haskard D.O., Coucher J.R., Gall N.P., Johnson-Tidey R.R. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am. J. Pathol. 1992;140:665–673 . [PMC free article] [PubMed] [Google Scholar]
  7. Johnson-Tidey R.R., McGregor J.L., Taylor P.R., Poston R.N. Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Am. J. Pathol. 1994;144:952–961 . [PMC free article] [PubMed] [Google Scholar]
  8. Nakashima Y., Raines E.W., Plump A.S., Breslow J.L., Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 1998;18:842–851 . doi: 10.1161/01.atv.18.5.842. [DOI] [PubMed] [Google Scholar]
  9. Li H., Cybulsky M.I., Jr., Gimbrone M.A., Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler. Thromb. 1993;13:197–204 . doi: 10.1161/01.atv.13.2.197. [DOI] [PubMed] [Google Scholar]
  10. Breslow J.L. Mouse models of atherosclerosis. Science. 1996;272:685–688 . doi: 10.1126/science.272.5262.685. [DOI] [PubMed] [Google Scholar]
  11. Dong Z.M., Wagner D.D. Leukocyte-endothelium adhesion molecules in atherosclerosis. J. Lab. Clin. Med. 1998;132:369–375 . doi: 10.1016/s0022-2143(98)90107-x. [DOI] [PubMed] [Google Scholar]
  12. Patel S.S., Thiagarajan R., Willerson J.T., Yeh E.T. Inhibition of α4 integrin and ICAM-1 markedly attenuate macrophage homing to atherosclerotic plaques in ApoE-deficient mice. Circulation. 1998;97:75–81 . doi: 10.1161/01.cir.97.1.75. [DOI] [PubMed] [Google Scholar]
  13. Mach F., Schonbeck U., Sukhova G.K., Atkinson E., Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 1998;394:200–203 . doi: 10.1038/28204. [DOI] [PubMed] [Google Scholar]
  14. Qiao J.H., Tripathi J., Mishra N.K., Cai Y., Tripathi S., Wang X.P., Imes S., Fishbein M.C., Clinton S.K., Libby P. Role of macrophage colony-stimulating factor in atherosclerosisstudies of osteopetrotic mice. Am. J. Pathol. 1997;150:1687–1699 . [PMC free article] [PubMed] [Google Scholar]
  15. de Villiers W.J., Smith J.D., Miyata M., Dansky H.M., Darley E., Gordon S. Macrophage phenotype in mice deficient in both macrophage-colony-stimulating factor (op) and apolipoprotein E. Arterioscler. Thromb. Vasc. Biol. 1998;18:631–640 . doi: 10.1161/01.atv.18.4.631. [DOI] [PubMed] [Google Scholar]
  16. Boring L., Gosling J., Cleary M., Charo I.F. Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 1998;394:894–897 . doi: 10.1038/29788. [DOI] [PubMed] [Google Scholar]
  17. Nageh M., Sandberg E.T., Marotti K.R., Lin A.H., Melchior E.P., Bullard D.C., Beaudet A.L. Deficiency of inflammatory cell adhesion molecules protects against atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 1997;17:1517–1520 . doi: 10.1161/01.atv.17.8.1517. [DOI] [PubMed] [Google Scholar]
  18. Johnson R.C., Chapman S.M., Dong Z.M., Ordovas J.M., Mayadas T.N., Herz J., Hynes R.O., Schaefer E.J., Wagner D.D. Absence of P-selectin delays fatty streak formation in mice. J. Clin. Invest. 1997;99:1037–1043 . doi: 10.1172/JCI119231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dong Z.M., Chapman S.M., Brown A.A., Frenette P.S., Hynes R.O., Wagner D.D. The combined role of P- and E-selectins in atherosclerosis. J. Clin. Invest. 1998;102:145–152 . doi: 10.1172/JCI3001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Bullard D.C., Kunkel E.J., Kubo H., Hicks M.J., Lorenzo I., Doyle N.A., Doerschuk C.M., Ley K., Beaudet A.L. Infectious susceptibility and severe deficiency of leukocyte rolling and recruitment in E-selectin and P-selectin double mutant mice. J. Exp. Med. 1996;183:2329–2336 . doi: 10.1084/jem.183.5.2329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Frenette P.S., Mayadas T.N., Rayburn H., Hynes R.O., Wagner D.D. Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell. 1996;84:563–574 . doi: 10.1016/s0092-8674(00)81032-6. [DOI] [PubMed] [Google Scholar]
  22. Ramos C.L., Huo Y., Jung U., Ghosh S., Manka D.R., Sarembock I.J., Ley K. Direct demonstration of P-selectin- and VCAM-1 dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ. Res. 1999;84:1237–1244 . doi: 10.1161/01.res.84.11.1237. [DOI] [PubMed] [Google Scholar]
  23. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 1992;89:4471–4475 . doi: 10.1073/pnas.89.10.4471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343–353 . doi: 10.1016/0092-8674(92)90362-g. [DOI] [PubMed] [Google Scholar]
  25. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468–471 . doi: 10.1126/science.1411543. [DOI] [PubMed] [Google Scholar]
  26. Reddick R.L., Zhang S.H., Maeda N. Atherosclerosis in mice lacking apoE. Evaluation of lesional development and progression. Arterioscler. Thromb. 1994;14:141–147 . doi: 10.1161/01.atv.14.1.141. [DOI] [PubMed] [Google Scholar]
  27. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., Ross R. ApoE-deficient mice develop lesions on all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 1994;14:133–140 . doi: 10.1161/01.atv.14.1.133. [DOI] [PubMed] [Google Scholar]
  28. Sligh J.E., Ballantyne C.M., Rich S.S., Hawkins H.K., Smith C.W., Bradley A., Beaudet A.L. Inflammatory and immune responses are impaired in ICAM-1 deficient mice. Proc. Natl. Acad. Sci. USA. 1993;90:8529–8533 . doi: 10.1073/pnas.90.18.8529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Bullard D.C., Qin L., Lorenzo I., Quinlin W.M., Doyle N.A., Bosse R., Vestweber D., Doerschuk C.M., Beaudet A.L. P-selectin/ICAM-1 double mutant miceacute emigration of neutrophils into the peritoneum is completely absent but is normal into pulmonary alveoli. J. Clin. Invest. 1995;95:1782–1788 . doi: 10.1172/JCI117856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Cole T., Kitchens R., Daugherty A., Schonfeld G. An improved method for separation of triglyceride-rich lipoproteins by FPLC. FPLC BioCommuniqué. 1988;4:4–6 . [Google Scholar]
  31. Guevara N.V., Kim H.-S., Antonova E.I., Chan L. The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo. Nat. Med. 1999;5:335–339 . doi: 10.1038/6585. [DOI] [PubMed] [Google Scholar]
  32. Springer T.A., Cybulsky M.I. Traffic signals on endothelium for leukocytes in health, inflammation, and atherosclerosis. In: Fuster V., Ross R., Topol E.J., editors. Atherosclerosis and Coronary Artery Disease. Lippincott-Raven; Philadelphia : 1996. pp. 511–538. [Google Scholar]
  33. Kalra V.K., Ying Y., Deemer K., Natarajan R., Nadler J.L., Coates T.D. Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultured endothelial cells. J. Cell. Physiol. 1994;160:154–162 . doi: 10.1002/jcp.1041600118. [DOI] [PubMed] [Google Scholar]
  34. Blann A.D., Kirkpatrick U., Devine C., Naser S., McCollum C.N. The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis. 1998;141:133–139 . [PubMed] [Google Scholar]
  35. Bergmann S., Siekmeier R., Mix C., Jaross W. Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1. Respir. Physiol. 1998;114:269–275 . doi: 10.1016/s0034-5687(98)00098-x. [DOI] [PubMed] [Google Scholar]
  36. Kim J.A., Berliner J.A., Natarajan R.D., Nadler J.L. Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes. 1994;43:1103–1107 . doi: 10.2337/diab.43.9.1103. [DOI] [PubMed] [Google Scholar]
  37. Cosentino F., Luscher T.F. Endothelial dysfunction in diabetes mellitus. J. Cardiovasc. Pharmacol. 1998;32:S54–S61 . [PubMed] [Google Scholar]
  38. Wautier J.L., Guillausseau P.J. Diabetes, advanced glycation endproducts and vascular disease. Vasc. Med. 1998;3:131–137 . doi: 10.1177/1358836X9800300207. [DOI] [PubMed] [Google Scholar]
  39. Nagel T., Resnick N., Atkinson W.J., Dewey C.F., Jr., Gimbrone M.A., Jr. Shear stress selectively upregulates intercellular adhesion molecule-1 expression in cultured human vascular endothelial cells. J. Clin. Invest. 1994;94:885–891 . doi: 10.1172/JCI117410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Kim J.A., Territo M.C., Wayner E., Carlos T.M., Parhami F., Smith C.W., Haberland M.E., Fogelman A.M., Berliner J.A. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler. Thromb. 1994;14:427–433 . doi: 10.1161/01.atv.14.3.427. [DOI] [PubMed] [Google Scholar]
  41. Klouche M., May A.E., Hemmes M., Mebetaner M., Kanse S.M., Preissner K.T., Bhakdi S. Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers. Arterioscler. Thromb. Vasc. Biol. 1999;19:784–793 . doi: 10.1161/01.atv.19.3.784. [DOI] [PubMed] [Google Scholar]
  42. Fruebis J., Gonzalez V., Silvestre M., Palinski W. Effect of probucol treatment on gene expression of VCAM-1, MCP-1, and M-CSF in the aortic wall of LDL receptor-deficient rabbits during early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 1997;17:1289–1302 . doi: 10.1161/01.atv.17.7.1289. [DOI] [PubMed] [Google Scholar]
  43. Rohde L.K., Lee R.T., Rivero J., Jamacochian M., Arroyo L.H., Briggs W., Rifai N., Libby P., Creager M.A., Ridker P.M. Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 1998;18:1765–1770 . doi: 10.1161/01.atv.18.11.1765. [DOI] [PubMed] [Google Scholar]
  44. Wenzel K., Ernst M., Rohde K., Baumann G., Speer A. DNA polymorphisms in adhesion molecule genes—a new risk factor for early atherosclerosis. Hum. Genet. 1996;97:15–20 . doi: 10.1007/BF00218826. [DOI] [PubMed] [Google Scholar]
  45. Herrmann S.M., Ricard S., Nicaud V., Mallet C., Evans A., Ruidavets J.B., Arveiler D., Lue G., Cambien F. The P-selectin gene is highly polymorphicreduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum. Mol. Genet. 1998;7:1277–1284 . doi: 10.1093/hmg/7.8.1277. [DOI] [PubMed] [Google Scholar]
  46. Wenzel K., Blackburn A., Ernst M., Affeldt M., Hanke R., Baumann G., Felix S.B., Kleber F.X., Rohde K., Glaser C. Relationship of polymorphisms in the renin-angiotensin system and in E-selectin of patients with early severe coronary heart disease. J. Mol. Med. 1997;75:57–61 . doi: 10.1007/s001090050087. [DOI] [PubMed] [Google Scholar]
  47. Ye S.Q., Usher D., Virgil D., Zhang L.Q., Yochim S.E., Gupta R. A PstI polymorphism detects the mutation of serine128 to arginine in CD 62E gene—a risk factor for coronary artery disease. J. Biomed. Sci. 1999;6:18–21 . doi: 10.1007/BF02256419. [DOI] [PubMed] [Google Scholar]
  48. Allen S., Khan S., Sp. Tam M., Koschinsky P., Taylor, Yacoub M. Expression of adhesion molecules by lp(a)a potential novel mechanism for its atherogenicity. FASEB (Fed. Am. Soc. Exp. Biol.) J. 1998;12:1765–1776. doi: 10.1096/fasebj.12.15.1765. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES